Preclinical Rheumatic Disease, An Issue of Rheumatic Disease Clinics, 1st Edition
Author :
Vivian P. Bykerk
The ability to intervene at the earliest phases in the pathogenesis of a chronic rheumatic disease caused by auto-inflammatory, autoimmune, or tissue injury mechanisms has th epotential to prevent disease manifestations and consequences, limited loss ...view more
The ability to intervene at the earliest phases in the pathogenesis of a chronic rheumatic disease caused by auto-inflammatory, autoimmune, or tissue injury mechanisms has th epotential to prevent disease manifestations and consequences, limited loss of quality of life, comorbidity, and costs to society. This issue is dedicated to exploring the stages of rheumatic disease, biologic mechanisms contributing to the pathogenesis along with possible ways to study and screen for persons at risk with the ultimate goal of finding ways to prevent these devastating diseases.
The ability to intervene at the earliest phases in the pathogenesis of a chronic rheumatic disease caused by auto-inflammatory, autoimmune, or tissue injury mechanisms has th epotential to prevent disease manifestations and consequences, limited loss of quality of life, comorbidity, and costs to society. This issue is dedicated to exploring the stages of rheumatic disease, biologic mechanisms contributing to the pathogenesis along with possible ways to study and screen for persons at risk with the ultimate goal of finding ways to prevent these devastating diseases.
Author Information
By Vivian P. Bykerk, BSc, MD, FRCPC, Hospital for Special Surgery, New York, NY
https://www.us.elsevierhealth.com/preclinical-rheumatic-disease-an-issue-of-rheumatic-disease-clinics-9780323320245.html1335Preclinical Rheumatic Disease, An Issue of Rheumatic Disease Clinicshttps://www.us.elsevierhealth.com/media/catalog/product/9/7/9780323320245.jpg69.2998.99USDInStock/Medicine/Rheumatology/Clinics/Clinics174388725525504113841826925145120The ability to intervene at the earliest phases in the pathogenesis of a chronic rheumatic disease caused by auto-inflammatory, autoimmune, or tissue injury mechanisms has th epotential to prevent disease manifestations and consequences, limited loss of quality of life, comorbidity, and costs to society. This issue is dedicated to exploring the stages of rheumatic disease, biologic mechanisms contributing to the pathogenesis along with possible ways to study and screen for persons at risk with the ultimate goal of finding ways to prevent these devastating diseases. The ability to intervene at the earliest phases in the pathogenesis of a chronic rheumatic disease caused by auto-inflammatory, autoimmune, or tissue injury mechanisms has th epotential to prevent disease manifestations and consequences, limited loss of quality of life, comorbidity, and costs to society. This issue is dedicated to exploring the stages of rheumatic disease, biologic mechanisms contributing to the pathogenesis along with possible ways to study and screen for persons at risk with the ultimate goal of finding ways to prevent these devastating diseases.00add-to-cart97803233202452014ProfessionalBy Vivian P. Bykerk, BSc, MD, FRCPC20141Book152w x 229h (6.00" x 9.00")Elsevier0Oct 19, 2014IN STOCK - This may take up to 5 business days to shipBy <STRONG>Vivian P. Bykerk</STRONG>, BSc, MD, FRCPC, Hospital for Special Surgery, New York, NYClinicsClinicsThe Clinics: Internal MedicineNoNoNoNoPlease SelectPlease SelectPlease Select
